4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Exosomes are the phospholipid-membrane-bound subpopulation of extracellular vesicles derived from the plasma membrane. The main activity of exosomes is cellular communication. In cancer, exosomes play an important rolefrom two distinct perspectives, one related to carcinogenesis and the other as theragnostic and drug delivery tools. The outer phospholipid membrane of Exosome improves drug targeting efficiency. . Some of the vital features of exosomes such as biocompatibility, low toxicity, and low immunogenicity make it a more exciting drug delivery system. Exosome-based drug delivery is a new innovative approach to cancer treatment. Exosome-associated biomarker analysis heralded a new era of cancer diagnostics in a more specific way. This Review focuses on exosome biogenesis, sources, isolation, interrelationship with cancer and exosome-related cancer biomarkers, drug loading methods, exosome-based biomolecule delivery, advances and limitations of exosome-based drug delivery, and exosome-based drug delivery in clinical settings studies. The exosome-based understanding of cancer will change the diagnostic and therapeutic approach in the future.

          Related collections

          Most cited references158

          • Record: found
          • Abstract: found
          • Article: not found

          Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

          Exosomes are vesicles of endocytic origin released by many cells. These vesicles can mediate communication between cells, facilitating processes such as antigen presentation. Here, we show that exosomes from a mouse and a human mast cell line (MC/9 and HMC-1, respectively), as well as primary bone marrow-derived mouse mast cells, contain RNA. Microarray assessments revealed the presence of mRNA from approximately 1300 genes, many of which are not present in the cytoplasm of the donor cell. In vitro translation proved that the exosome mRNAs were functional. Quality control RNA analysis of total RNA derived from exosomes also revealed presence of small RNAs, including microRNAs. The RNA from mast cell exosomes is transferable to other mouse and human mast cells. After transfer of mouse exosomal RNA to human mast cells, new mouse proteins were found in the recipient cells, indicating that transferred exosomal mRNA can be translated after entering another cell. In summary, we show that exosomes contain both mRNA and microRNA, which can be delivered to another cell, and can be functional in this new location. We propose that this RNA is called "exosomal shuttle RNA" (esRNA).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Extracellular vesicles: Exosomes, microvesicles, and friends

            Cells release into the extracellular environment diverse types of membrane vesicles of endosomal and plasma membrane origin called exosomes and microvesicles, respectively. These extracellular vesicles (EVs) represent an important mode of intercellular communication by serving as vehicles for transfer between cells of membrane and cytosolic proteins, lipids, and RNA. Deficiencies in our knowledge of the molecular mechanisms for EV formation and lack of methods to interfere with the packaging of cargo or with vesicle release, however, still hamper identification of their physiological relevance in vivo. In this review, we focus on the characterization of EVs and on currently proposed mechanisms for their formation, targeting, and function.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

              Unresectable locally advanced or metastatic triple-negative (hormone-receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)-paclitaxel may enhance the anticancer activity of atezolizumab.
                Bookmark

                Author and article information

                Journal
                ACS Biomater Sci Eng
                ACS Biomater Sci Eng
                ab
                abseba
                ACS Biomaterials Science & Engineering
                American Chemical Society
                2373-9878
                09 January 2023
                13 February 2023
                : 9
                : 2
                : 577-594
                Affiliations
                []Department of Medical Biotechnology, Ramakrishna Mission Vivekananda Educational and Research Institute , Howrah, West Bengal 711202, India
                []Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology , Kattankulathur, Tamil Nadu 603203, India
                [§ ]Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham , Kochi, Kerala 682041, India
                []Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology (VIT) , Vellore, Tamil Nadu 632014, India
                []Rush University Medical Center , 1620 W Harrison St, Chicago, Illinois 60612, United States
                [# ]Department of Microbiology, West Bengal State University , Kolkata, West Bengal 700126, India
                [g ]Department of Health Sciences, Novel Global Community Educational Foundation , https://www.ngcef.net/
                [h ]Raiganj Government Medical College and Hospital , Raiganj, West Bengal 733134, India
                [i ]Department of Microbiology, Vels Institute of Science, Technology and Advanced Studies , Pallavaram, Chennai 600117, Tamilnadu, India
                [j ]Jawaharlal Nehru Medical college , Wardha, Maharashtra 442001, India
                [k ]Microbiology Division, Department of Botany, Gauhati University , Guwahati, Assam 781014, India
                [l ]Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Free State , Bloemfontein, Free State 9300, South Africa
                [m ]Nuffield Department of Women’s and Reproductive Health, Division of Medical Sciences, John Radcliffe Hospital, University of Oxford , Oxford OX1 2JD, United Kingdom
                [n ]Department of Physics, Bernal Institute and Limerick Digital Cancer Research Centre (LDCRC) University of Limerick , Castletroy, Limerick V94T9PX, Ireland
                Author notes
                Author information
                https://orcid.org/0000-0001-6343-527X
                Article
                10.1021/acsbiomaterials.2c01329
                9930096
                36621949
                9068d223-ef8b-418b-913c-c61ce815e353
                © 2023 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 05 November 2022
                : 19 December 2022
                Funding
                Funded by: Science Foundation Ireland, doi 10.13039/501100001602;
                Award ID: 21/PATH-S/9634
                Categories
                Review
                Custom metadata
                ab2c01329
                ab2c01329

                eexosomes,cancer,drug loading methods,drug delivery,cancer biomarker

                Comments

                Comment on this article